Elizabethkingia meningoseptica : Emerging nosocomial pathogen in bedside hemodialysis patients

Indian Journal of Critical Care Medicine

Volumn 17, Issue 5, 2013, Pages 304-307

  Ratnamani, M ^a   Rao, Ratna ^a  

^a APOLLO HOSPITAL   (India)

Author keywords

Colistin resistance; Elizabethkingia meningoseptica; hemodialysis

Indexed keywords

CEFOPERAZONE PLUS SULBACTAM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; DRUG USE; ELIZABETHKINGIA MENINGOSEPTICA; ELIZABETHKINGIA MENINGOSEPTICA INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; HEALTHCARE ASSOCIATED INFECTION; HEMODIALYSIS PATIENT; HUMAN; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; PRESCHOOL CHILD; RISK FACTOR;

EID: 84889654349     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.120323     Document Type: Article

References (20)

1. Ceyhan M, Yildirim I, Tekeli A, Yurdakok M, Us E, Altun B, et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control 2008;36:453-7.
2. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997;76:30-41. (Pubitemid 27074740)
3. Chiu CH, Waddingdon M, Greenberg D, Schreckenberger PC, Carnahan AM. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg Infect Dis 2000;6:481-6.
4. Hoque SN, Graham J, Kaufmann ME, Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect 2001;47:188-92. (Pubitemid 32631846)
5. du Moulin GC. Airway colonization by Flavobacterium in an intensive care unit. J Clin Microbiol 1979;10:155-60.
6. Nulens E, Bussels B, Bols A, Gordts B, van Landuyt HW. Recurrent bacteremia by Elizabethkingae indologenes in an oncology patient with a totally implanted intravenous device. Clin Microbiol Infect 2001;7:391-3. (Pubitemid 34960325)
7. Lee CH, Lin WC, Chia JH, Su LH, Chien C, Mao AH, et al. Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: Case report and literature review. Diagn Microbiol Infect Dis 2008;60:89-93. (Pubitemid 350235163)
8. Adachi A, Mori T, Simizu T, Yokoyama A, Takayama N, Ikeda Y, et al. Chryseobacterium meningosepticum septicemia in a recipient of allogeneic cord blood transplantation. Scand J Infect Dis 2004;36:539-40. (Pubitemid 39089226)
9. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: Report from the SENTRY antimicrobial surveillance program (1997-2001). J Clin Microbiol 2004;42:445-8. (Pubitemid 38082768)
10. Güngör S, Ozen M, Akinci A, Durmaz R. A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol 2003;24:613-7. (Pubitemid 37039621)
11. Maraki S, Scoulica E, Manoura A, Papageorgiou N, Giannakopoulou C, Galanakis E. A Chryseobacterium meningosepticum colonization outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2009;28:1415-9.
12. Bellais S, Poire L, Naas T, Girlich D, Nordmann P. Genetic biochemical analysis and distribution of the Ambler class A-lactamase CME-2, responsible for extended spectrum cephalosporin resistance in Elizabethkingae (Flavobacterium) meningosepticum. Antimicrob Agents Chemother 2000;44:1-9. (Pubitemid 30010663)
13. Steinberg JP, Burd EM. Other gram-negative and gram-variable bacilli. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 3015-33.
14. Chen GX, Zhang RH, Zhou W. Heterogeneity of metallo-lactamases in clinical isolates of Elizabethkingae meningosepticum from Hangzhou China. J Antimicrob Chemother 2006;57:750-2.
15. Amer MZ, Bandey M, Bukhari A, Nemenqani D. Neonatal meningitis which was caused by Elizabethkingia meningoseptica in Saudi Arabia. J Infect Dev Ctries 2011;5:745-7.
16. Pereira GH, de Oliveira Garcia D, Abboud CS, et al. Nosocomial infections caused by Elizabethkingia meningoseptica: An emergent pathogen. Braz J Infec Dis 2013;17:606-9.
17. Hawley HB, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child 1973;126:261-4.
18. Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 1997;41:1301-6.
19. Husson MO, Izard D, Bouillet L, Lecherc H. Comparative in-vitro activity of ciprofloxacin against nonfermentors. J Antimicrob Chemother 1985;15:457-62. (Pubitemid 15114330)
20. Martin K, Crisp C, Jurgensen JH. Outbreak of Flavobacterium meningosepticum in a surgical intensive care unit (SICU). Abstract M52 in Proceedings of the Program and Abstracts of the 5th Annual meeting of the Society for Healthcare Epidemiology of America (SHEA 1995), San Diego, Calif, USA.